Harvard Apparatus Regenerative Technology Debt/Equity Ratio 2013-2024 | HRGN

Harvard Apparatus Regenerative Technology debt/equity ratio from 2013 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Harvard Apparatus Regenerative Technology Debt/Equity Ratio 2013-2024 | HRGN

Harvard Apparatus Regenerative Technology debt/equity ratio from 2013 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$126B
Cencora (COR)$46.2B
ICON (ICLR)$24.1B
DiDi Global (DIDIY)$18.8B
Avantor (AVTR)$18.3B
Natera (NTRA)$15.7B
Revvity (RVTY)$15.1B
Viatris (VTRS)$14.1B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$12.5B
Medpace Holdings (MEDP)$11B
Charles River Laboratories (CRL)$10.6B
Sonic Healthcare (SKHHY)$8.9B
Doximity (DOCS)$7.5B
HealthEquity (HQY)$6.9B
Bausch + Lomb (BLCO)$6.5B
PACS (PACS)$6.2B
Organon (OGN)$5.3B
Life Times (LTH)$4.9B
Sotera Health (SHC)$4.7B
Surgery Partners (SGRY)$4B
Concentras Parent (CON)$2.9B
GoodRx Holdings (GDRX)$2.9B
BrightSpring Health Services (BTSG)$2.5B
Ardent Health Partners (ARDT)$2.5B
Progyny (PGNY)$2.2B
Alignment Healthcare (ALHC)$2.2B
Premier (PINC)$2.1B
Ryman Healthcare (RYHTY)$2B
AMN Healthcare Services Inc (AMN)$1.8B